The U.S. Food and Drug Administration (FDA) is warning that blood pressure drug olmesartan medoxomil, marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics, can cause intestinal problems known as sprue-like enteropathy.
Symptoms of...
Drugmaker Sued by U.S. Employees for Gender Discrimination
Six current and former female sales representatives are accusing Japanese North American division drugmaker, Daiichi Sankyo, of gender discrimination in a $100 million class action lawsuit.
The lawsuit states the women are trying to put an end...